Methods and Pharmaceutical Compositions Using Orexins (OXA, OXB) for the Treatment of Prostate Cancers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15531128

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to methods and pharmaceutical compositions for the treatment of prostate cancers. In particular, the present invention relates to an OX1R agonist for use in the treatment of prostate cancer in a subject in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)PARIS FRA
UNIVERSITE PARIS DIDEROT - PARIS 75 RUE THOMAS MANN PARIS 75013
UNIVERSITE DE ROUEN76821 MONT-SAINT-AIGNAN CÉDEX

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alexandre, David Mont Saint Aignan Cedex, FR 2 21
Anouar, Youssef Mont Saint Aignan Cedex, FR 2 1
Chartrel, Nicolas Mont Saint Aignan Cedex, FR 1 1
Couvineau, Alain Paris Cedex 18, FR 13 6
Jeandel, Lydie Mont Saint Aignan Cedex, FR 1 1
Leprince, Jerome Mont Saint Aignan Cedex, FR 1 1
Voisin, Thierry Paris Cedex 18, FR 12 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation